Literature DB >> 34034566

A Nationwide Survey of COVID-19 Testing in LGBTQ+ Populations in the United States.

Richard J Martino1, Kristen D Krause1,2, Marybec Griffin1, Caleb LoSchiavo1,2, Camilla Comer-Carruthers1, Anita G Karr1, Allie F Bullock1, Perry N Halkitis1,3,4.   

Abstract

OBJECTIVES: Lesbian, gay, bisexual, transgender, or queer and questioning (LGBTQ+) people and populations face myriad health disparities that are likely to be evident during the COVID-19 pandemic. The objectives of our study were to describe patterns of COVID-19 testing among LGBTQ+ people and to differentiate rates of COVID-19 testing and test results by sociodemographic characteristics.
METHODS: Participants residing in the United States and US territories (N = 1090) aged ≥18 completed an internet-based survey from May through July 2020 that assessed COVID-19 testing and test results and sociodemographic characteristics, including sexual orientation and gender identity (SOGI). We analyzed data on receipt and results of polymerase chain reaction (PCR) and antibody testing for SARS-CoV-2 and symptoms of COVID-19 in relation to sociodemographic characteristics.
RESULTS: Of the 1090 participants, 182 (16.7%) received a PCR test; of these, 16 (8.8%) had a positive test result. Of the 124 (11.4%) who received an antibody test, 45 (36.3%) had antibodies. Rates of PCR testing were higher among participants who were non-US-born (25.4%) versus US-born (16.3%) and employed full-time or part-time (18.5%) versus unemployed (10.8%). Antibody testing rates were higher among gay cisgender men (17.2%) versus other SOGI groups, non-US-born (25.4%) versus US-born participants, employed (12.6%) versus unemployed participants, and participants residing in the Northeast (20.0%) versus other regions. Among SOGI groups with sufficient cell sizes (n > 10), positive PCR results were highest among cisgender gay men (16.1%).
CONCLUSIONS: The differential patterns of testing and positivity, particularly among gay men in our sample, confirm the need to create COVID-19 public health messaging and programming that attend to the LGBTQ+ population.

Entities:  

Keywords:  COVID-19; LGBTQ+; coronavirus; sexual and gender minority

Mesh:

Year:  2021        PMID: 34034566      PMCID: PMC8203041          DOI: 10.1177/00333549211018190

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   3.117


  62 in total

Review 1.  Sexual orientation and mental health.

Authors:  Gregory M Herek; Linda D Garnets
Journal:  Annu Rev Clin Psychol       Date:  2007       Impact factor: 18.561

Review 2.  Moving toward a holistic conceptual framework for understanding healthy aging among gay men.

Authors:  Perry N Halkitis; Farzana Kapadia; Danielle C Ompad; Rafael Perez-Figueroa
Journal:  J Homosex       Date:  2015-01-08

3.  Primary Care Providers' Attitudes Related to LGBTQ People: A Narrative Literature Review.

Authors:  Mollie E Aleshire; Kristin Ashford; Amanda Fallin-Bennett; Jennifer Hatcher
Journal:  Health Promot Pract       Date:  2018-06-27

4.  Beliefs about HIV non-infection and risky sexual behavior among MSM.

Authors:  Perry N Halkitis; David D Zade; Michael Shrem; Michael Marmor
Journal:  AIDS Educ Prev       Date:  2004-10

5.  A population-based study of sexual orientation identity and gender differences in adult health.

Authors:  Kerith J Conron; Matthew J Mimiaga; Stewart J Landers
Journal:  Am J Public Health       Date:  2010-06-01       Impact factor: 9.308

6.  Lesbian, gay, and bisexual homeless youth: an eight-city public health perspective.

Authors:  James M Van Leeuwen; Susan Boyle; Stacy Salomonsen-Sautel; D Nico Baker; J T Garcia; Allison Hoffman; Christian J Hopfer
Journal:  Child Welfare       Date:  2006 Mar-Apr

7.  Are sociodemographic, lifestyle, and psychosocial characteristics associated with sexual orientation group differences in mental health disparities? Results from a national population-based study.

Authors:  Evan A Krueger; Dawn M Upchurch
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-01-02       Impact factor: 4.328

8.  Black-White Risk Differentials in COVID-19 (SARS-COV2) Transmission, Mortality and Case Fatality in the United States: Translational Epidemiologic Perspective and Challenges.

Authors:  Laurens Holmes; Michael Enwere; Janille Williams; Benjamin Ogundele; Prachi Chavan; Tatiana Piccoli; Chinaka Chinacherem; Camillia Comeaux; Lavisha Pelaez; Osatohamwen Okundaye; Leslie Stalnaker; Fanta Kalle; Keeti Deepika; Glen Philipcien; Maura Poleon; Gbadebo Ogungbade; Hikma Elmi; Valescia John; Kirk W Dabney
Journal:  Int J Environ Res Public Health       Date:  2020-06-17       Impact factor: 3.390

9.  State-level tracking of COVID-19 in the United States.

Authors:  H Juliette T Unwin; Swapnil Mishra; Valerie C Bradley; Axel Gandy; Thomas A Mellan; Helen Coupland; Jonathan Ish-Horowicz; Michaela A C Vollmer; Charles Whittaker; Sarah L Filippi; Xiaoyue Xi; Mélodie Monod; Oliver Ratmann; Michael Hutchinson; Fabian Valka; Harrison Zhu; Iwona Hawryluk; Philip Milton; Kylie E C Ainslie; Marc Baguelin; Adhiratha Boonyasiri; Nick F Brazeau; Lorenzo Cattarino; Zulma Cucunuba; Gina Cuomo-Dannenburg; Ilaria Dorigatti; Oliver D Eales; Jeffrey W Eaton; Sabine L van Elsland; Richard G FitzJohn; Katy A M Gaythorpe; William Green; Wes Hinsley; Benjamin Jeffrey; Edward Knock; Daniel J Laydon; John Lees; Gemma Nedjati-Gilani; Pierre Nouvellet; Lucy Okell; Kris V Parag; Igor Siveroni; Hayley A Thompson; Patrick Walker; Caroline E Walters; Oliver J Watson; Lilith K Whittles; Azra C Ghani; Neil M Ferguson; Steven Riley; Christl A Donnelly; Samir Bhatt; Seth Flaxman
Journal:  Nat Commun       Date:  2020-12-03       Impact factor: 14.919

10.  COVID-19 exacerbating inequalities in the US.

Authors:  Aaron van Dorn; Rebecca E Cooney; Miriam L Sabin
Journal:  Lancet       Date:  2020-04-18       Impact factor: 79.321

View more
  7 in total

1.  Statewide Evaluation of SARS-CoV-2 Diagnoses and Sexual Orientation and Gender Identity.

Authors:  Tracy L Jackson; Philip A Chan; Nfn Scout; Lauren S Nocera; Denise Crooks; Winston McCormick; Sarah Bowman; Leanne Lasher; Amir Sabet Sarvestani; Laura C Chambers
Journal:  Public Health Rep       Date:  2022-03-03       Impact factor: 3.117

2.  Public Health Reports in 2021: Impact Factor Increase and New Article Collections on Racism and COVID-19.

Authors:  Andrey Kuzmichev; Noelle M Harada; Derek M Griffith; Krista M Powell; Hazel D Dean
Journal:  Public Health Rep       Date:  2022-04-18       Impact factor: 3.117

3.  Sexual Behavior Change Among Gay and Bisexual Men During the First COVID-19 Pandemic Wave in the United States.

Authors:  Tara McKay; Jeff Henne; Gilbert Gonzales; Kyle A Gavulic; Rebecca Quarles; Sergio Garcia Gallegos
Journal:  Sex Res Social Policy       Date:  2021-08-20

4.  Prevalence and Correlates of SARS CoV-2 Among a Community-Based Sample Recruited Using Randomized Venue-Based Sampling. Essex County, NJ, 2020.

Authors:  Henry F Raymond; Pratik Datta; Rahul Ukey; Peng Wang; Richard J Martino; Kristen D Krause; Corey Rosmarin-DeStefano; Abraham Pinter; Perry N Halkitis; Maria L Gennaro
Journal:  J Racial Ethn Health Disparities       Date:  2021-11-08

5.  Employment Loss as a Result of COVID-19: a Nationwide Survey at the Onset of COVID-19 in US LGBTQ+ Populations.

Authors:  Richard J Martino; Kristen D Krause; Marybec Griffin; Caleb LoSchiavo; Camilla Comer-Carruthers; Perry N Halkitis
Journal:  Sex Res Social Policy       Date:  2021-11-13

6.  Disparities in Mental Health and Well-Being between Heterosexual and Sexual Minority Older Adults during the COVID-19 Pandemic.

Authors:  Jen-Hao Chen
Journal:  J Aging Health       Date:  2022-04-16

7.  Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIV.

Authors:  Pamina M Gorbach; Alison D Rosen; Richard Moore; Steve Shoptaw; Brian Mustanski; Shruti H Mehta; Gregory D Kirk; Marianna K Baum; M-J Milloy; Kanna Hayashi; Kora DeBeck; Michele Kipke; Shenghan Lai; Suzanne Siminski; Marjan Javanbakht
Journal:  Drug Alcohol Depend       Date:  2022-09-06       Impact factor: 4.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.